↓ Skip to main content

Cochrane Database of Systematic Reviews

Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
6 tweeters

Citations

dimensions_citation
109 Dimensions

Readers on

mendeley
166 Mendeley
citeulike
1 CiteULike
Title
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd008623.pub2
Pubmed ID
Authors

Layli Eslami, Shahin Merat, Reza Malekzadeh, Siavosh Nasseri-Moghaddam, Hermineh Aramin

Abstract

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are common causes of elevated liver enzymes in the general population. NASH and to some extent NAFLD have been associated with increased liver-related and all-cause mortality. No effective treatment is yet available. Recent reports have shown that the use of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) in patients with elevated plasma aminotransferases may result in normalisation of these liver enzymes. Whether this is a consistent effect or whether it can lead to improved clinical outcomes beyond normalisation of abnormal liver enzymes is not clear.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Ireland 1 <1%
Australia 1 <1%
South Africa 1 <1%
United Kingdom 1 <1%
Mexico 1 <1%
Spain 1 <1%
Unknown 159 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 16%
Student > Bachelor 25 15%
Researcher 23 14%
Other 16 10%
Student > Ph. D. Student 13 8%
Other 28 17%
Unknown 34 20%
Readers by discipline Count As %
Medicine and Dentistry 74 45%
Nursing and Health Professions 15 9%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Biochemistry, Genetics and Molecular Biology 7 4%
Neuroscience 3 2%
Other 12 7%
Unknown 46 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2016.
All research outputs
#3,284,429
of 17,360,236 outputs
Outputs from Cochrane database of systematic reviews
#5,894
of 11,660 outputs
Outputs of similar age
#49,674
of 273,228 outputs
Outputs of similar age from Cochrane database of systematic reviews
#87
of 153 outputs
Altmetric has tracked 17,360,236 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,228 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 153 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.